Other News To Note
Cellerant Therapeutics Inc., of San Carlos, Calif., said it was awarded a Small Business Innovation Research Phase I contract and a Phase II option from the National Cancer Institute valued up to about $1.7 billion.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter